An official American thoracic society/european respiratory society statement: The role of the pulmonologist in the diagnosis and management of lung cancer

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 4, 2013, Pages 503-507

  Gaga, Mina ^a   Powell, Charles A ^a   Schraufnagel, Dean E ^a   Schonfeld, Nicolas ^a   Rabe, Klaus ^a   Hill, Nicholas S ^a   Sculier, Jean Paul ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; RADON;

AIR POLLUTION; ARTICLE; BOARD OF TRUSTEES; BRONCHOSCOPY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; EXHAUST GAS; HUMAN; IMMUNE DEFICIENCY; LUNG CANCER; LUNG FIBROSIS; LUNG INFECTION; MEDICAL SOCIETY; MEDICAL SPECIALIST; ONCOLOGY; PALLIATIVE THERAPY; PLEURA EFFUSION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PULMONOLOGIST; RESPIRATORY FAILURE; RESTAGING; SMOKING; SMOKING CESSATION PROGRAM; TERMINAL CARE; THORACOSCOPY; TRANSBRONCHIAL ASPIRATION;

EUROPE; FELLOWSHIPS AND SCHOLARSHIPS; HUMANS; LUNG NEOPLASMS; PATIENT CARE TEAM; PHYSICIAN'S ROLE; PULMONARY MEDICINE; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84882590495     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201307-1269ST     Document Type: Article

References (38)

1. Aberle DR, Adams AM, Berg CD, BlackWC, Clapp JD, FagerstromRM, Gareen IF, Gatsonis C,Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. BulmanW, Saqi A, Powell CA. Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy. Am J Respir Crit Care Med 2012; 185:606-611.
3. Department of Health Statistics and Informatics, World Health Organization. Causes of death 2008: summary tables. Geneva, Switzerland: World Health Organization; 2011.
4. Malvezzi M,Arfé A, Bertuccio P, Levi F, La Vecchia C, Negri E. European cancer mortality predictions for the year 2011. AnnOncol 2011;22:947-956.
5. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
6. Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5:e9584.
7. KrisMG, Benowitz SI, Adams S, Diller L, Ganz P, KahlenbergMS, Le QT, Markman M, Masters GA, Newman L, et al. Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 2010;28:5327-5347.
8. Pastorino U. Lung cancer screening. Br J Cancer 2010;102:1681-1686.
9. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307: 2418-2429.
10. Powell CA, Halmos B, Nana-Sinakam SP. Update in lung cancer and mesothelioma 2012. Am J Respir Crit Care Med 2013;188:157-166.
11. Scagliotti G, Brodowicz T, Shepherd FA, Zielinski C, Vansteenkiste J, Manegold C, Simms L, Fossella F, Sugarman K, Belani CP. Treatmentby- histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer. J Thorac Oncol 2011;6:64-70.
12. Cheng H, Xu X, Costa DB, Powell CA, Halmos B. Molecular testing in lung cancer: the time is now. Curr Oncol Rep 2010;12:335-348.
13. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.
14. Nakajima T, KimuraH, Takeuchi K, SodaM,Mano H, Yasufuku K, Iizasa T. Treatment of lung cancer with an ALK inhibitor after EML4-ALK fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration. J Thorac Oncol 2010;5:2041-2043.
15. Nakajima T, Yasufuku K, Nakagawara A, Kimura H, Yoshino I.Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest 2011;140:1319-1324.
16. Rekhtman N, Brandt SM, Sigel CS, Friedlander MA, Riely GJ, Travis WD, Zakowski MF, Moreira AL. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol 2011;6:451-458.
17. Sakairi Y, Nakajima T, Yasufuku K, Ikebe D, Kageyama H, Soda M, Takeuchi K, Itami M, Iizasa T, Yoshino I, et al. EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Clin Cancer Res 2010;16:4938-4945.
18. Kligerman S, Digumarthy S. Staging of non-small cell lung cancer using integrated PET/CT. AJR Am J Roentgenol 2009;193:1203-1211.
19. Szlubowski A, Kuzdzal J, Kolodziej M, Soja J, Pankowski J, Obrochta A, Kopinski P, Zielinski M. Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging. Eur J Cardiothorac Surg 2009;35:332-335, discussion 335-336.
20. Hwangbo B, Kim SK, Lee HS, Lee HS, Kim MS, Lee JM, Kim HY, Lee GK, Nam BH, Zo JI. Application of endobronchial ultrasound- guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer. Chest 2009;135:1280-1287.
21. Herth FJ, Ernst A, Eberhardt R, Vilmann P, Dienemann H, Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum. Eur Respir J 2006;28:910-914.
22. Brunelli A, Charloux A, Bolliger CT, Rocco G, Sculier JP, Varela G, Licker M, Ferguson MK, Faivre-Finn C, Huber RM, et al.; European Respiratory Society and European Society of Thoracic Surgeons Joint Task Force on Fitness for Radical Therapy. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009;34:17-41.
23. Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg 2010;38:1-5.
24. Bolliger CT, Sutedja TG, Strausz J, Freitag L. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J 2006;27:1258-1271.
25. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez- Panadero F, Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-1539.
26. Blum T, Schönfeld N, Kollmeier J, Ammenwerth W, Grüning W, Nehls W, Bauer TT. Lungenkrebs in Deutschland-zur Versorgungslage der Nation. Pneumologie 2011;65:7-18.
27. Taylor C, Munro AJ, Glynne-Jones R, Griffiths C, Trevatt P, Richards MA, Ramirez AJ. Multidisciplinary team working in cancer: where are we now? BMJ 2010;340:c951.
28. Lamb BW, Brown KF, Nagpal K, Vincent C, Green JSA, Sevdalis N. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 2011;18:2116-2125.
29. Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:7S-37S.
30. Loddenkemper R, Dierkesmann R, Konietzko N, Kropp R, Wiesner B, Seehausen V. [100 years DGP-100 years of pneumology in Germany] [article in German]. Pneumologie 2010;64:7-17.
31. Forrest LM, McMillan DC, McArdle CS, Dunlop DJ. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 2005;93:977-978.
32. National Collaborating Centre for Acute Care. The diagnosis and treatment of lung cancer: Methods, evidence and guidance. London: National Collaborating Centre for Acute Care; 2005 [accessed 2013 Jul]. Available from: http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdf
33. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005;55:231-240.
34. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-3103.
35. Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, et al.; German Respiratory Society; German Cancer Society. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 2011;65:39-59.
36. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Salle F, Hennequin C, Hillerdal G, et al.; European Respiratory Society/European Society of Thoracic Surgeons Task Force. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010;35:479-495.
37. Sculier JP, Vansteenkiste J, Schönfeld N, Scherpereel A. Thoracic oncology in Europe: the ERS action plan by the Thoracic Oncology Assembly. Eur Respir J 2010;36:1227-1228.
38. European Initiative for Quality Management in Lung Cancer Care (EIQMLCC). European initiative in quality management of lung cancer care [accessed 2013 Jul]. Available from: http://eiqmlcc.medsite. org/